| abstract |
The present invention relates to compositions and methods for enhancing the absorption of S-adenosylmethionine (SAMe) and to the treatment of various diseases or disorders using non-injectable SAMe agents with enhanced absorption and improved bioavailability. Enhanced bioavailability agents can be used in a variety of diseases or disorders, including mental anxiety disorders, obsessive compulsive disorder, post-traumatic stress disorder, panic disorder, depressive disorders (eg major clinical depression), and mood disorders. And can be used to treat liver disease, cancer, autoimmune disease, inflammatory disease, joint disease, gastrointestinal disease and cardiovascular disease. |